DRI Healthcare (DHTRF) Price & Analysis

1 Followers

DHTRF Stock Chart & Stats

$12.66

$0.00(0.00%)

At close: Jun 22 4:00 PM EDT

$12.66

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$9.83 - $13.93

Previous CloseN/A

Volume35.00

Average Volume (3M)764.00

Market Cap

$701.08M

Enterprise Value$1.57B

Total Cash (Recent Filing)$55.16M

Total Debt (Recent Filing)$439.44M

Price to Earnings (P/E)―

Beta0.21

Next Earnings

Nov 04, 2026

EPS Estimate

0.72

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.78

Shares Outstanding54,973,545

10 Day Avg. Volume585

30 Day Avg. Volume764

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)1.06

Price to Sales (P/S)2.38

P/FCF Ratio-40.68

Enterprise Value/Market Cap2.24

Enterprise Value/Revenue7.72

Enterprise Value/Gross Profit40.15

Enterprise Value/Ebitda10.17

Forecast

1Y Price Target

$16.69

Price Target Upside31.83% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering5

EPS Forecast (FY)2.54

Revenue Forecast (FY)$191.87M

Bulls Say, Bears Say

Bulls Say

High-Margin Cash GenerationA 92% adjusted EBITDA margin and rising cash receipts show the royalty model can convert drug-linked revenue into substantial operating cash. If margins remain near management’s high-80s to 90% outlook, this supports distributions and reinvestment.

Royalty Portfolio GrowthRoyalty income has grown nearly 18% over two years while Q2 rose 8% year over year, indicating portfolio-level expansion rather than reliance solely on milestones. Continued growth would improve cash-flow visibility and support redeployment.

New Royalty Asset CatalystFDA approval triggered the $75M milestone and starts royalties in Q3, adding a new commercial asset to the portfolio. Expected broader access and a permanent J-code could make Lumvoa a multi-year contributor, though the ramp is not immediate.

Bears Say

Net Losses And LeverageTTM net margin is about -22%, ROE is roughly -10%, and debt-to-equity is about 1.01. This combination indicates operating strength is not yet translating into durable bottom-line returns and leaves less flexibility if royalty receipts weaken.

Product And Generic CompetitionOmidria, Spinraza and Zytiga receipts declined, with Zytiga affected by European generic entry, while Rydapt is stepping down. These pressures show product-specific competition, lifecycle effects and concentration can offset portfolio-level growth.

Portfolio Duration And Redeployment RiskThe Ekterly disposition removes a longer-duration asset and may reduce near-term receipts, making portfolio cash flows more dependent on successful redeployment. This raises execution risk because replacement assets may take time to mature and may not match prior durability.

DRI Healthcare News

DRI Healthcare Trust price target raised to C$27 from C$26 at Stifel

Stifel raised the firm’s price target on DRI Healthcare Trust (DHTRF) to C$27 from C$26 and keeps a...

18d ago

DRI Healthcare Trust price target raised to C$22 from C$21 at RBC Capital

RBC Capital raised the firm’s price target on DRI Healthcare Trust (DHTRF) to C$22 from C$21 and keeps...

25d ago

DRI Healthcare Schedules Q3 2026 Results Release and Investor Call

An announcement from DRI Healthcare ( ($TSE:DHT.UN) ) is now available. DRI Healthcare Trust will release its third...

3d ago

DRI Healthcare Buys Parkinson’s Drug Royalties After FDA Clears Juvmo

DRI Healthcare ( ($TSE:DHT.UN) ) has provided an announcement. DRI Healthcare Trust is deepening its exposure to neurology...

19d ago

DRI Healthcare: Buy Rating Backed by Tavapadon Royalty Deal, Adding C$1.35 per Unit to Target Price and Enhancing Upside Potential

Analyst David Martin PhD of Bloom Burton maintained a Buy rating on DRI Healthcare, with a price target...

22d ago

DRI Healthcare to Spend US$316 Million on Tavapadon Parkinson’s Royalty Deal

DRI Healthcare ( ($TSE:DHT.UN) ) has shared an announcement. DRI Healthcare Trust has agreed to acquire royalty participation...

26d ago

Dri Healthcare Trust Delivers Record Earnings, Eyes Growth

Dri Healthcare Plc Trust (($TSE:DHT.UN)) has held its Q2 earnings call. Read on for the main highlights of...

2M ago

DRI Healthcare Posts Record Q1 Income and Bolsters Balance Sheet With New Funding

DRI Healthcare ( ($TSE:DHT.UN) ) has provided an announcement. DRI Healthcare Trust reported record first-quarter total income of...

2M ago

DRI Healthcare Realizes US$178 Million from EKTERLY Royalty Exit

DRI Healthcare ( ($TSE:DHT.UN) ) has provided an update. DRI Healthcare Trust has received approximately US$178 million from...

2M ago

DRI Healthcare Posts Record Q2 Results, Executes Ekterly Put and Adds Biopharma Experts to Board

DRI Healthcare ( ($TSE:DHT.UN) ) has issued an announcement. DRI Healthcare reported record second-quarter 2026 results, with total...

2M ago

DHT.UN Upcoming Earnings Report: What to Expect?

Dri Healthcare Plc Trust (DHT.UN) is scheduled to report 2nd quarter earnings on 08/07/2026, after the market closes....

2M ago

DRI Healthcare Trust price target raised to C$25 from C$24 at Stifel

Stifel raised the firm’s price target on DRI Healthcare Trust (DHTRF) to C$25 from C$24 and keeps a...

3M ago

DRI Healthcare Trust price target raised to C$21 from C$20 at CIBC

CIBC analyst Erin Kyle raised the firm’s price target on DRI Healthcare Trust (DHTRF) to C$21 from C$20...

3M ago

DRI Healthcare Trust price target raised to C$23 from C$22 at Stifel

Stifel analyst Justin Keywood raised the firm’s price target on DRI Healthcare Trust (DHTRF) to C$23 from C$22...

5M ago

DHTRF FAQ

What was DRI Healthcare’s price range in the past 12 months?

DRI Healthcare lowest stock price was $9.83 and its highest was $13.93 in the past 12 months.

What is DRI Healthcare’s market cap?

DRI Healthcare’s market cap is $701.08M.

When is DRI Healthcare’s upcoming earnings report date?

DRI Healthcare’s upcoming earnings report date is Nov 04, 2026 which is in 18 days.

How were DRI Healthcare’s earnings last quarter?

DRI Healthcare released its earnings results on Aug 07, 2026. The company reported $0.552 earnings per share for the quarter, missing the consensus estimate of $0.588 by -$0.036.

Is DRI Healthcare overvalued?

According to Wall Street analysts DRI Healthcare’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does DRI Healthcare pay dividends?

DRI Healthcare does not currently pay dividends.

What is DRI Healthcare’s EPS estimate?

DRI Healthcare’s EPS estimate is 0.72.

How many shares outstanding does DRI Healthcare have?

DRI Healthcare has 54,973,545 shares outstanding.

What happened to DRI Healthcare’s price movement after its last earnings report?

DRI Healthcare reported an EPS of $0.552 in its last earnings report, missing expectations of $0.588. Following the earnings report the stock price went up 4.151%.

Which hedge fund is a major shareholder of DRI Healthcare?

Currently, no hedge funds are holding shares in DHTRF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

DRI Healthcare Stock Smart Score

Outperform

Fundamentals

Return on Equity

-10.07%

Trailing 12-Months

Asset Growth

5.13%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

DRI Healthcare

DRI Healthcare Trust is an unincorporated open-ended company. It engages in the provision of differentiated exposure to the fast-growing pharmaceutical and biotechnology industries through ownership and acquisition of royalties on pharmaceutical products with a focus on delivering attractive growth in cash receipts from royalty assets over the long term. The company was founded in 1989 and is headquartered in Toronto, Canada.

DRI Healthcare (DHTRF) Earnings & Revenues

Historic Earnings Reports

DHTRF Stock 12 Month Forecast

Average Price Target

$16.69

▲(31.83% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"$9","20":"$20","11.75":"$11.75","14.5":"$14.5","17.25":"$17.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":19.013346,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$19.01</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.689492599999998,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$16.69</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.788158,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.79</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,11.75,14.5,17.25,20],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.86,13.333334307692308,13.806668615384615,14.280002923076923,14.75333723076923,15.226671538461538,15.700005846153845,16.17334015384615,16.64667446153846,17.12000876923077,17.593343076923077,18.06667738461538,18.54001169230769,{"y":19.013346,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.86,13.154576353846153,13.449152707692306,13.74372906153846,14.038305415384615,14.332881769230768,14.627458123076922,14.922034476923075,15.216610830769229,15.511187184615384,15.805763538461537,16.10033989230769,16.394916246153844,{"y":16.689492599999998,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.86,13.008319846153846,13.156639692307692,13.304959538461539,13.453279384615383,13.60159923076923,13.749919076923076,13.898238923076923,14.046558769230769,14.194878615384615,14.34319846153846,14.491518307692306,14.639838153846153,{"y":14.788158,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":10.246,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.541,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.568,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.426,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.825,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.922,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.689,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.881,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.466,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.894,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.141,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.771,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.86,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >